Top Banner
How animal models inform potential therapies for immune dysfunction in PANDAS/PANS Dritan Agalliu, Ph.D. Departments of Neurology, Pathology & Cell Biology and Pharmacology Columbia Translational Neuroscience Initiative Columbia University Medical Center
37

How animal models inform potential therapies for immune ...pandasnetwork.org/wp-content/uploads/2018/10/Day-2-Agalliu_NYC_Parent_Talk_030518.pdfHow animal models inform potential therapies

Feb 12, 2020

Download

Documents

dariahiddleston
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: How animal models inform potential therapies for immune ...pandasnetwork.org/wp-content/uploads/2018/10/Day-2-Agalliu_NYC_Parent_Talk_030518.pdfHow animal models inform potential therapies

How animal models inform potential therapies for immune dysfunction in PANDAS/PANS

Dritan Agalliu, Ph.D. Departments of Neurology, Pathology & Cell Biology

and Pharmacology Columbia Translational Neuroscience Initiative

Columbia University Medical Center

Page 2: How animal models inform potential therapies for immune ...pandasnetwork.org/wp-content/uploads/2018/10/Day-2-Agalliu_NYC_Parent_Talk_030518.pdfHow animal models inform potential therapies

Disclosures

Consultant for Hughes, Hubbard and Reed LLP

Funding : NIH / NHLBI R01HL116995 NIH / NIMH NIMH R01MH112849 NIH / NCTSA (CUMC CAMPRII – BASIC) International OCD Foundation Newport Equities LLC (private donation) PANDAS Network

Page 3: How animal models inform potential therapies for immune ...pandasnetwork.org/wp-content/uploads/2018/10/Day-2-Agalliu_NYC_Parent_Talk_030518.pdfHow animal models inform potential therapies

Infection, autoimmunity and behavior: The quest for a link

Page 4: How animal models inform potential therapies for immune ...pandasnetwork.org/wp-content/uploads/2018/10/Day-2-Agalliu_NYC_Parent_Talk_030518.pdfHow animal models inform potential therapies

Autoantibodies disrupt communication between neurons

NMDAR NMDARAMPAR

glutamate

D1R D1RD2R

dopamine

Access to the brain? Access to the brain?

Page 5: How animal models inform potential therapies for immune ...pandasnetwork.org/wp-content/uploads/2018/10/Day-2-Agalliu_NYC_Parent_Talk_030518.pdfHow animal models inform potential therapies

The blood-brain barrier: an important gatekeeper between the blood and the central nervous system

• Maintains brain homeostasis • Limits CNS entry of

– pathogens – immune cells – drugs

Evans blue dye

Page 6: How animal models inform potential therapies for immune ...pandasnetwork.org/wp-content/uploads/2018/10/Day-2-Agalliu_NYC_Parent_Talk_030518.pdfHow animal models inform potential therapies

Abnormal blood-brain barrier function is a prominent feature of many CNS diseases

Multiple sclerosis

Bruce Trapp

• Acute traumatic injury

• Stroke

• Exposure to toxic or hypertonic conditions

• Brain infections

• Autoimmune diseases - Multiple sclerosis - Autoimmune Encephalitis?

• Neurodegenerative diseases • Alzheimer’s • Huntington’s • Parkinson’s

Acute ischemic stroke

Yu et al. (2015)

Page 7: How animal models inform potential therapies for immune ...pandasnetwork.org/wp-content/uploads/2018/10/Day-2-Agalliu_NYC_Parent_Talk_030518.pdfHow animal models inform potential therapies

Engelhardt & Ransohoff, 2012 Trends Immunol Huppert, J. et al., 2010 FASEB Okada & Khoury, 2012 JCI Risau W. et al., 1990 JCB

Hypothesis 1: Destruction of tight junctions between endothelial cells

Page 8: How animal models inform potential therapies for immune ...pandasnetwork.org/wp-content/uploads/2018/10/Day-2-Agalliu_NYC_Parent_Talk_030518.pdfHow animal models inform potential therapies

Zhang, D. et al., 2012 Brain Behav Immun Abuqayyas & Balthasar, 2012 Mol Pharmaceutics Okun, E. et al., 2010 Neuromol Med Diamond, B. et al., 2013 Ann Rev Immunol

Hypothesis 2: Selective transport of antibodies from endothelial cells into the brain

Page 9: How animal models inform potential therapies for immune ...pandasnetwork.org/wp-content/uploads/2018/10/Day-2-Agalliu_NYC_Parent_Talk_030518.pdfHow animal models inform potential therapies

Group A β-hemolytic Streptococcus pyogenes causes a plethora of autoimmune diseases

Implicated in autoimmunity Scarlet fever

Rheumatic fever

Glomerulonephritis

Sydenham’s chorea PANDAS

heart

kidney

Skin (viral toxin)brain

Page 10: How animal models inform potential therapies for immune ...pandasnetwork.org/wp-content/uploads/2018/10/Day-2-Agalliu_NYC_Parent_Talk_030518.pdfHow animal models inform potential therapies

Neurological symptoms in SC and PANDAS

Chorea Hypotonia

Cardiac involvement Hyperactivity Obsessions

time

sym

ptom

sev

erity

Choreiform movements Tics

Severe separation anxiety Urinary frequency

Food refusal / anorexia

Emotional lability OCD-like symptoms

Contamination fears

SC PANDAS

Page 11: How animal models inform potential therapies for immune ...pandasnetwork.org/wp-content/uploads/2018/10/Day-2-Agalliu_NYC_Parent_Talk_030518.pdfHow animal models inform potential therapies

S. pyogenes activates both arms of the immune system: humoral (antibodies) and cellular (Th17 cells).

S. pyogenes

Generation of Th17 cells after multiple intranasal infections

% o

f CD

4+ 2

W T

cel

ls

with

Cyt

okin

e ph

enot

ype

Perc

enta

ge o

f T

cells

IFNγ

Dileepan et al., (2011). PLoS Pathogens

Page 12: How animal models inform potential therapies for immune ...pandasnetwork.org/wp-content/uploads/2018/10/Day-2-Agalliu_NYC_Parent_Talk_030518.pdfHow animal models inform potential therapies

Patients’ serum autoantibodies bind neurons and activate neuronal signaling

100%C

aMK

II A

ctiv

atio

n

PANDAS non-PANDASSC

p < 0.0001

CaM kinase

TH-(P)

Dopamine

Dopamine release Unwanted movement

Autoantibody

Kirvan, C. et al. (2006), J Neuroimmunol Kirvan, C. et al. (2003), Nat Med

Page 13: How animal models inform potential therapies for immune ...pandasnetwork.org/wp-content/uploads/2018/10/Day-2-Agalliu_NYC_Parent_Talk_030518.pdfHow animal models inform potential therapies

Autoantibodies can bind post-synaptic D1R and D2R receptors

D1R D1RD2R

SC: D2R, D1R or ratio of D2R/D1R titers correlate with symptoms

PANDAS: D2R; Mixed reportsdopamine

Ben-Pazi, H. et al., 2012 J Mol Neurosci Ben-Pazi, H. et al., 2013 PLoS One Brilot, F. et al., 2011 Neurology Dale, R. C. et al., 2012 Brain Kirvan, C. et al., 2006 J Neuroimm Kirvan, C. et al., 2003 Nat Med

Access to the brain?

Page 14: How animal models inform potential therapies for immune ...pandasnetwork.org/wp-content/uploads/2018/10/Day-2-Agalliu_NYC_Parent_Talk_030518.pdfHow animal models inform potential therapies

Outline

1. What is the role of S. pyogenes-specific Th17 lymphocytes in post-infectious basal ganglia encephalitis?

2. Are Th17 lymphocytes necessary for the development of disease in the brain?

Page 15: How animal models inform potential therapies for immune ...pandasnetwork.org/wp-content/uploads/2018/10/Day-2-Agalliu_NYC_Parent_Talk_030518.pdfHow animal models inform potential therapies

GAS or PBS

Intranasal

Weekly i.n. GAS or PBS

i.v. tracer, sac

Experiment day 0 7 14 21 28 30

A novel rodent model to understand the impact of the immune system on the brain after S. pyogenes infections

GAS T cells

Dileepan T et al., (2011) PLoS Pathogens; Dileepan T., Smith E. et al., 2016 J Clin Invest

Page 16: How animal models inform potential therapies for immune ...pandasnetwork.org/wp-content/uploads/2018/10/Day-2-Agalliu_NYC_Parent_Talk_030518.pdfHow animal models inform potential therapies

Hypothesis: Dysregulated Th17 immune response to S. pyogenes infections is key to understanding “autoimmune” complications associated with this pathogen.

Immune pathology

Normal immune response

protection

Th17 cellular immune response:

a balance between protection and disease

Page 17: How animal models inform potential therapies for immune ...pandasnetwork.org/wp-content/uploads/2018/10/Day-2-Agalliu_NYC_Parent_Talk_030518.pdfHow animal models inform potential therapies

0

125

250

375

500

Bregma 4.28 Bregma 3.2 Bregma 2.46 Bregma 1.54 Bregma 0.26 Bregma -0.94 Bregma -2.46

Naïve 1 Inf 6H 4 Inf 6H

Aver

age

num

ber o

f C

D4+

T-C

ells

/ 1

2µm

S. pyogenes-specific CD4+ T lymphocytes are present in the brain after multiple intranasal infections.

*** ***

** *

Dileepan T., Smith E. et al., 2016 J Clin Invest

Page 18: How animal models inform potential therapies for immune ...pandasnetwork.org/wp-content/uploads/2018/10/Day-2-Agalliu_NYC_Parent_Talk_030518.pdfHow animal models inform potential therapies

Does the route of GAS infections determine entry of Th17 cells into the brain?

PTx i.v.

GAS or PBS CFA emulsion GAS or PBS

Subcutaneous Intranasal

Weekly i.n. GAS or PBS

sac

Experiment day 0 7 14 21 28 30

Biweekly s.c. emulsion

sac

Experiment day 0 14 28 30

Platt M. et al. (unpublished)

Page 19: How animal models inform potential therapies for immune ...pandasnetwork.org/wp-content/uploads/2018/10/Day-2-Agalliu_NYC_Parent_Talk_030518.pdfHow animal models inform potential therapies

Only intranasal GAS infections promote entry of Th17 cells into the brain

Platt M. et al. (unpublished)

Page 20: How animal models inform potential therapies for immune ...pandasnetwork.org/wp-content/uploads/2018/10/Day-2-Agalliu_NYC_Parent_Talk_030518.pdfHow animal models inform potential therapies

The route of inoculation determines immune outcome

Subcutaneous Intranasal

T cell phenotype Th1 Th17, Th1

T cells in the CNS Few Many

Microglia activation Some Robust

Glomerular synapse loss

N/A Degraded

Anti-GAS titer High High

BBB permeability Adjuvants High

Behavioral deficits Perseveration Motor deficits

Mild motor deficits

Platt M. et al. (unpublished)

Page 21: How animal models inform potential therapies for immune ...pandasnetwork.org/wp-content/uploads/2018/10/Day-2-Agalliu_NYC_Parent_Talk_030518.pdfHow animal models inform potential therapies

S. pyogenes CD4+ T cells in the brain are associated with neuroinflammation

Dileepan T., Smith E. et al., 2016 J Clin Invest

Page 22: How animal models inform potential therapies for immune ...pandasnetwork.org/wp-content/uploads/2018/10/Day-2-Agalliu_NYC_Parent_Talk_030518.pdfHow animal models inform potential therapies

Do Th17 cells in the brain affect the integrity of blood vessels?

GAS or PBS

Intranasal

Weekly i.n. GAS or PBS

i.v. tracer, sac

Experiment day 0 7 14 21 28 30

Biocytin-TMR

Dileepan T., Smith E. et al., 2016 J Clin Invest

Page 23: How animal models inform potential therapies for immune ...pandasnetwork.org/wp-content/uploads/2018/10/Day-2-Agalliu_NYC_Parent_Talk_030518.pdfHow animal models inform potential therapies

The integrity of the blood-brain barrier is compromised after multiple S. pyogenes infections.

Naive

GAS-6H

Dileepan T., Smith E. et al., 2016 J Clin Invest

Page 24: How animal models inform potential therapies for immune ...pandasnetwork.org/wp-content/uploads/2018/10/Day-2-Agalliu_NYC_Parent_Talk_030518.pdfHow animal models inform potential therapies

LH

OT

GAS-specific Th17 lymphocytes may disrupts blood-brain barrier tight junctions

Dileepan T., Smith E. et al., 2016 J Clin Invest

Page 25: How animal models inform potential therapies for immune ...pandasnetwork.org/wp-content/uploads/2018/10/Day-2-Agalliu_NYC_Parent_Talk_030518.pdfHow animal models inform potential therapies

Are Th17 cells present in tonsils from PANDAS children?

• S. pyogenes subtypes may be important for disease pathogenesis

• Genetic risk factors for SC and PANDAS

• Repeated infections with S. pyogenes or other pathogens that generate Th17 cells.

• Presence of both Th17 cells and autoantibodies is important for disease pathogenesis

Dileepan T., Smith E. et al., 2016 J Clin Invest

Page 26: How animal models inform potential therapies for immune ...pandasnetwork.org/wp-content/uploads/2018/10/Day-2-Agalliu_NYC_Parent_Talk_030518.pdfHow animal models inform potential therapies

Novel pathway for T cell entry into the CNS

Dileepan T., Smith E. et al., 2016 J Clin Invest

Page 27: How animal models inform potential therapies for immune ...pandasnetwork.org/wp-content/uploads/2018/10/Day-2-Agalliu_NYC_Parent_Talk_030518.pdfHow animal models inform potential therapies

Outline

1. What is the role of S. pyogenes-specific Th17 lymphocytes in post-infectious basal ganglia encephalitis?

2. Are Th17 lymphocytes necessary for the development of disease in the brain?

Page 28: How animal models inform potential therapies for immune ...pandasnetwork.org/wp-content/uploads/2018/10/Day-2-Agalliu_NYC_Parent_Talk_030518.pdfHow animal models inform potential therapies

Visualizing the presence of Th17 lymphocytes in the brain using RORγt+/GFP mice

Martin Lipp & Gerd Müller, Lymphoid organogenesis: getting the green light from RORt Nature Immunology 5, 12 - 14 (2004) doi:10.1038/ni0104-12

GAS or PBS

Intranasal

Weekly i.n. GAS or PBS

sac

Experiment day 0 7 14 21 28 30

Platt M. et al. (unpublished)

DAPI GFP CD4

Page 29: How animal models inform potential therapies for immune ...pandasnetwork.org/wp-content/uploads/2018/10/Day-2-Agalliu_NYC_Parent_Talk_030518.pdfHow animal models inform potential therapies

Th17 cells are a subset of total CD4+ T lymphocytes in the CNS after multiple S. pyogenes infections

~32.5% Th17To

tal C

D4+

T c

ells

per

12

um O

B s

ectio

n

0

175

350

525

700

WT HET

Perc

enta

ge la

bele

d Th

17

cells

in O

B

0%

11%

23%

34%

45%

WT HET

DAPI GFP CD4

RORγt+/GFP

Platt M. et al. (unpublished)

Page 30: How animal models inform potential therapies for immune ...pandasnetwork.org/wp-content/uploads/2018/10/Day-2-Agalliu_NYC_Parent_Talk_030518.pdfHow animal models inform potential therapies

RORγtc-/- mice have fewer CD4+ T cells in the brain after multiple S. pyogenes infections

n=5

n=8

n=8

Platt M. et al. (unpublished)

Page 31: How animal models inform potential therapies for immune ...pandasnetwork.org/wp-content/uploads/2018/10/Day-2-Agalliu_NYC_Parent_Talk_030518.pdfHow animal models inform potential therapies

Neuroinflammation is present in the brain in the absence of Th17 cells after multiple infections

n.s.

PBS GAS ROR -/-GAS ROR+/-

Platt M. et al. (unpublished)

Page 32: How animal models inform potential therapies for immune ...pandasnetwork.org/wp-content/uploads/2018/10/Day-2-Agalliu_NYC_Parent_Talk_030518.pdfHow animal models inform potential therapies

Blood-brain barrier is still damaged in the absence of Th17 lymphocytes after multiple S. pyogenes infections

PBS GAS ROR-/-GAS ROR+/-

IgG

Glu

t1Ig

G G

lut1

n.s.

n.s.

Platt M. et al. (unpublished)

PBS GAS ROR-/-GAS ROR+/-

Page 33: How animal models inform potential therapies for immune ...pandasnetwork.org/wp-content/uploads/2018/10/Day-2-Agalliu_NYC_Parent_Talk_030518.pdfHow animal models inform potential therapies

Th17 cells are not required to damage synapses after multiple S. pyogenes infections

Platt M. et al. (unpublished)

Page 34: How animal models inform potential therapies for immune ...pandasnetwork.org/wp-content/uploads/2018/10/Day-2-Agalliu_NYC_Parent_Talk_030518.pdfHow animal models inform potential therapies

S. pyogenes-infected mice have blunted olfactory perception regardless of the presence or absence of Th17 cells

Platt M. et al. (unpublished)

Page 35: How animal models inform potential therapies for immune ...pandasnetwork.org/wp-content/uploads/2018/10/Day-2-Agalliu_NYC_Parent_Talk_030518.pdfHow animal models inform potential therapies

Th17 and Th1 cells are present in the CNS after multiple GAS infections

Page 36: How animal models inform potential therapies for immune ...pandasnetwork.org/wp-content/uploads/2018/10/Day-2-Agalliu_NYC_Parent_Talk_030518.pdfHow animal models inform potential therapies

How can OCD/PANDAS research in animals inform clinical diagnosis and treatment?

• Test whether cytokine profiles characteristic of a Th17/Th1 phenotype are present in CSF from PANDAS patients.

• A “signature profile” for autoimmunity to ascertain diagnosis of PANDAS/PANS should be established.

• Develop novel, dynamic contrast-enhanced MRI imaging tools to detect blood-brain barrier dysfunction during periods of disease flares.

• Develop new immunotherapies targeted against Th17/Th1 cells, in conjunction with IVIG or plasmapheresis

Cutforth T., Agalliu, D et al., 2016 J Future Neurology

Page 37: How animal models inform potential therapies for immune ...pandasnetwork.org/wp-content/uploads/2018/10/Day-2-Agalliu_NYC_Parent_Talk_030518.pdfHow animal models inform potential therapies

Acknowledgements

University of Minnesota, Minneapolis Paul Patrick Cleary, Ph.D. Thamotharapail Dileepan, V.D.M., Ph.D.

Agalliu Laboratory Maryann Platt Tyler Cutforth, Ph.D. Erica Smith Ph.D. Charlotte Wayne Lauren Cuje M.S. Nicole Ampatey Sarah Chaudry

NIH / NHLBI R01HL116995 NIH / NIMH NIMH R01MH112849 NIH / NCTSA (CUMC CAMPRII International OCD Foundation Newport Equities LLC (private donation) PANDAS Network